Elekta announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma. The collaboration leverages Elekta's digital health interventions platform, Kaiku Health, to facilitate communication between healthcare professionals and their patients on symptom management. Elekta's digital solution will provide an accessible, user-friendly way for patients to share relevant information on their wellbeing with their care team, and to receive tailored support and guidance during treatment.

By utilizing machine learning algorithms, the platform will enable real-time evaluation of patient-reported data, providing healthcare providers with personalized insights that may improve patients' care pathway and care experience. Through personalized symptom monitoring, healthcare professionals can react early and focus on what matters, while enabling their patients to take a more active role in their treatment.